drugset / Trial / NCT05958342

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

NCT05958342

RandomizedSequentialQuadruple-blindTreatment

Summary

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

Timeline

Start
2024-06-30
Primary completion
2027-03
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 4 iu
Subject calcium gluconate Small molecule 1 g Intravenous

Indications